Gene Query: PROCR

Dataset Description Geneva Score
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 86.52
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 51.27
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 47.93
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 44.87
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 36.72
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 34.91
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 34.49
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 33.89
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 33.55
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 33.24
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 31.74
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 31.74
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 30.78
WRN knockout effects upon gene expression in SW48 and OVK18 30.23
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 29.42
RNA expression following TMPRSS11B overexpression or depletion 28.74
Generation of trichogenic adipose-derived stem cells by expression of three factors 28.07
RNA seq comparison between scrambled and shGRP78 cells 26.62
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 26.54
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 26.33
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 26.33
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 26.19
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 25.0
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 24.61
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 24.6
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 24.6
Differentially expressed genes post knock down of lincDUSP26 23.97
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 23.67
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 23.6
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 23.34
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 22.71
Investigation about fibroblasts of different origins in culture 21.98
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 21.87
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 21.49
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 21.43
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 21.17
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 20.75
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 20.08
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 20.06
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 20.02
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 19.77
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 19.72
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 19.2
RNA Seq of HMVEC under hypoxia 19.05
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 19.05
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 18.56
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 17.5
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 17.37
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 17.19
The regulartory role of ZCCHC24 in splicing machinery 16.9
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 16.64
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 16.36
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 16.2
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 16.2
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 15.59
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 15.59
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 15.54
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 15.54
EWSR1 influences alternative splicing through direct and indirect mechanisms 15.48
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 15.25
Mutational landscape of splicing genes and functional consequences across 33 cancer types 15.16
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 15.08
snRNAs as regulators of alternative splicing 14.95
A prostate cancer chromatin interaction map 14.81
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 14.79
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 14.74
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 14.33
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 14.14
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 14.1
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 13.98
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 13.79
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 13.13
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 13.13
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 13.08
Transcriptomic analysis of the HOTAIR-regulated genes 12.95
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.72
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.72
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 12.63
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 12.63
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 12.5
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 12.48
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 12.47
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 12.35
MOF acetyl transferase regulates transcription and respiration in mitochondria 12.32
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 12.31
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 12.28
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 12.14
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 12.11
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 12.07
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 12.03
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 12.0
Spliceosomal disruption of the non-canonical BAF complex in cancer 11.99
TGF-β promotes genomic instability after loss of RUNX3 11.91
RNA sequencing with KSHV infection and enrichment for circular RNAs 11.82
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 11.78
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 11.51
Nutritional control of protein translation 11.45
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 11.39
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 11.29
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 11.23
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 11.19
Genome-wide transcriptional response to random aneuploidy in human cells 11.16
Differetially expressed genes after hTR overexpression in U2OS cells 11.06
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 11.04
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 11.0
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 10.93
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 10.92
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 10.87
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 10.86
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 10.81
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 10.81
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 10.63
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 10.63
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 10.61
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 10.52
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 10.52
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 10.42
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.38
Differential gene expression of human melanoma cells [RNA-seq] 10.38
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 10.35
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 10.35
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 10.26
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 10.17
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 10.14
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 10.13
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 10.11
KLF6-dependent transcription in renal cancer cells 10.11
Redifferentiation of expanded human islet β cells by inhibition of ARX 10.1
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 10.1
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 10.07
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 10.04
Genome-wide analysis of the Integrator complex 9.94
Genome-wide analysis of the Integrator complex (HTS) 9.94
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 9.91
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.73
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 9.6
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 9.51
Exploring the RNA landscape of endothelial exosomes 9.5
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 9.41
Gene expression profiling of human and murine in vitro muscle differentiation 9.4
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 9.32
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.08
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 9.07
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 8.96
Rorc disruption in human FG pancreatic cancer cells 8.92
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 8.88
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 8.86
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.84
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.81
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 8.79
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 8.69
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 8.68
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 8.64
Gene expression analysis of immortalized human liver progenitor-like cells in culture 8.62
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 8.57
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.5
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 8.49
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 8.49
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 8.4
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 8.39
Tumor exosome integrins determine organotropic metastasis 8.39
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 8.39
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 8.32
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 8.27
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 8.23
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 8.19
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 8.17
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 8.17
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 8.16
Neonatal and adult human testis defined at the single-cell level 8.14
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 8.12
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 8.12
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.06
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.06
Identification of long noncoding RNAs regulated by p53 8.03
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 8.01
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 8.01
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 7.85
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 7.79
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 7.75
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 7.74
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 7.7
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 7.67
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 7.67
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 7.66
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.63
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 7.6
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 7.6
Lipid degradation promotes prostate cancer cell survival 7.57
Genome-wide analysis of Dengue virus 2 infected cells 7.47
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 7.4
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 7.4
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 7.4
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 7.4
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 7.37
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 7.35
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 7.35
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 7.34
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 7.34
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 7.33
A transcriptome dataset revealing the molecular features of breast cancer stem cells 7.27
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 7.27
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 7.26
The human blood-nerve barrier transcriptome 7.25
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.2
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 7.18
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 7.17
High-Throughput Kinetic Analysis of Fractional Killing 7.16
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 7.12
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 7.07
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 7.07
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 7.01
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.0
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.99
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 6.98
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 6.94
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 6.92
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 6.88
Differentially expressed vascular development genes for iPSC-ECs from CDI 6.82
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 6.75
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 6.74
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 6.73
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.71
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.71
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.71
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.7
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 6.66
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.65
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 6.62
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.62
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 6.6
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 6.6
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 6.51
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 6.48
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 6.45
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.41
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 6.38
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.33
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 6.33
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 6.32
LIN28A modulates splicing and gene expression programs in breast cancer cells 6.32
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 6.28
Ebola virus (EBOV) infection of ARPE-19 cells 6.27
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 6.26
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 6.26
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 6.19
Effect of ILF3 on translation during homeostasis and the antiviral response 6.14
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.11
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.09
Single cell transcriptome of peritoneal cells 6.09
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 6.08
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 6.07
Generation of KRAS signatures using immortalized isogenic lung cells. 6.07
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 6.06
RNA-seq of tumor cells following angiopellosis extravasation 6.01
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.99
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 5.98
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 5.98
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 5.94
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 5.91
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.89
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 5.87
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 5.79
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 5.79
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 5.79
RNA editing in nascent RNA affects pre-mRNA splicing 5.76
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.68
Knockdown of ADNP in HCT116 colon cancer cells 5.66
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 5.62
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 5.62
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 5.61
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 5.52
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 5.52
RNA sequencing of human mammary epithelial cells 5.47
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.44
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.42
Paxillin regulates genomic networks in prostate cancer [PC3] 5.4
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 5.39
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 5.38
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 5.38
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 5.34
Chromatin landscape of human visceral and subcutaneous adipocytes 5.29
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 5.29
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.27
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.27
BMS-470539 on human synovial fibroblasts 5.19
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 5.19
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 5.18
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 5.13
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.05
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 5.05
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 5.04
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 5.01
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.96
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 4.95
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 4.95
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.9
Profiling of escape kinetics of viruses subjected to RNAi 4.89
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 4.88
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.87
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.87
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 4.84
Gene profiling of human adult and pediatric liver cancer cells 4.83
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 4.83
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 4.72
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 4.7
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 4.7
Illumina Total RNA-seq in HeLa 4.69
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 4.69
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 4.67
Gene Expression Profiling of WT and KDM3A Knocked out Cell 4.62
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 4.62
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.6
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.56
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 4.56
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 4.49
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.47
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 4.44
RNA-seq of naive and primed ES cells 4.43
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 4.43
Finding missing proteins from epigenetically manipulated human cells 4.33
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 4.31
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 4.31
Cajal bodies are linked to genome conformation 4.29
Cajal bodies are linked to genome conformation [RNA-Seq] 4.29
Nucleoporin-mediated regulation of cell identity genes 4.25
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.23
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 4.2
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 4.2
Effect of nuclear IL-33 on gene expression 4.18
RNA-seq analysis of control and Myc-induced U2OS cells 4.18
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 4.06
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 4.03
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 3.98
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.9
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.9
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.9
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.88
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 3.83
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.8
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 3.8
Analysis of transcriptional regulation by Myt1 and Myt1l 3.79
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 3.78
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 3.78
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.77
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.77
6mer seed toxicity in tumour suppressive microRNAs 3.75
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.71
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.7
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 3.64
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 3.62
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 3.6
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.57
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.57
Gene expression profile of human placenta from T. Cruzi infected mothers 3.55
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.54
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.49
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.44
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.43
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.4
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 3.39
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 3.39
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 3.39
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 3.37
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.37
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.37
Single-cell analysis of adult human ovary using 10X genomics 3.36
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 3.36
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.33
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.33
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.31
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.3
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.3
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.3
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.26
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.22
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.22
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 3.2
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 3.17
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 3.16
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.15
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 3.09
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 3.05
RNA-seq of RKO cells with cTAZ KO or putback 3.04
Transcriptome analysis of virus infected tissues 3.03
The role of the Calcium-Sensing receptor in colorectal cancer 2.97
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.88
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.88
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 2.86
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 2.86
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.84
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.81
Molecular analysis of renal cell carcinoma with unclassfied histology 2.81
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 2.75
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.71
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 2.7
Real-time observation of light-controlled transcription in living cells 2.66
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.56
Transcriptomes in healthy and CHB fetal hearts 2.56
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.53
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 2.51
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.5
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.48
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.48
MRTF activates TEAD-YAP target gene expression 2.34
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.31
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.27
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.27
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.25
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.19
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.19
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.16
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.15
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 2.06
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 2.06
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.06
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.05
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.04
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.97
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.83
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.8
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.79
Deep RNA sequencing of the human placental transcriptome 1.73
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.62
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 1.59
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.58
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.58
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.52
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.5
RNA-seq of IL-4 stimulated human keratinocytes 1.5
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 1.48
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.44
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.41
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.41
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.39
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.38
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.34
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 1.33
Expression profiling of converted and control dermal BJ fibroblasts 1.29
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.29
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.28
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.27
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.24
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.21
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.19
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.19
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.17
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.17
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 1.11
The DPYSL2 gene connects mTOR and schizophrenia 1.11
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.09
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.09
RNA sequencing of human pancreatic cancer cell lines 1.06
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.03
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.03
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.01
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.99
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 0.96
RNA-sequencing in immortalized human mammary epithelial cells 0.96
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.95
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.91
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.84
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.82
Transcriptomic analysis of human macrophages in 3D 0.8
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.71
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.7
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.68
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.66
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.62
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.6
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.51
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.49
Epigenomic conservation of transposable element silencing 0.47
Epigenomic conservation of transposable element silencing [RNA-seq] 0.47
Identification of the role of polydom in neurofibromas 0.47
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.46
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.41
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.4
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.37
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.36
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.35
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.34
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.34
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.33
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.3
Gene expression profile of CRC-derived HILEC 0.3
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.29
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.29
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.29
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.29
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.26
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.26
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.24
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.24
Transcriptome of EBV-infected gastric cancer cell lines 0.22
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.19
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.11
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.07
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.07
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation